Cold Snare Endoscopic Resection for Duodenal Adenomas
COLD SNARE
1 other identifier
observational
10
1 country
1
Brief Summary
Non-ampullary sporadic duodenal adenomas (SDA) are rare lesions, incidentally discovered in up to only 5% of patients during routine endoscopy. In any case, these lesions require treatment due to their potential malignant transformation because of the adenoma-carcinoma sequence, occurring in 30-85% of cases. Endoscopic resection (ER) of SDA represents an attractive alternative to surgical resection in appropriately selected patients, with lower morbidity and mortality rates. However, most endoscopists are not keen to resect larger lesions due to the risk of complications. Indeed, endoscopic resection in the duodenum has unique challenges: thin wall, high vascularity, very limited space and harmful effects of bile and acid both acting on the ER defect. Cold snare endoscopic resection has been shown to be a viable method for removing colorectal lesions with comparable efficacy outcomes compared to conventional polypectomy/endoscopic mucosal resection (EMR) and a promising safety profile. As a matter of fact, adverse events associated with hot snare resection technique such as delayed bleeding, post-polypectomy syndrome, and perforation are all related to electrocautery-induced injury. Performing cold snare piece-meal resection and avoiding the need of thermal therapy, may have a major impact in the duodenum where the risk of delayed bleeding and perforation is consistent. The aim of this pilot study is to prospectively evaluate the feasibility and the efficacy in term of safety and efficacy of cold snare endoscopic resection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 2, 2021
CompletedFirst Posted
Study publicly available on registry
March 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedSeptember 15, 2022
September 1, 2022
10 months
March 2, 2021
September 13, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Number of patints that will have serious and non-serious adverse events
* endoscopic appearance * scar biopsies * perforation risk
3 Months
Number of residual adenomas
* endoscopic appearance * scar biopsies
3 Months
Secondary Outcomes (3)
Duration of endoscopic procedure
3 Months
Hospital stay
3 Months
Hospital readmission
3 Months
Interventions
Cold snare endoscopic resection
Eligibility Criteria
Patients with diagnosed large duodenal adenomas (\>20 mm)
You may qualify if:
- Patients able to give informed consent to involvement in trial.
You may not qualify if:
- Patient's with known strictures/stenosis
- Pregnancy
- Patients who did not consent to study
- Bleeding diathesis
- Anticoagulants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Endoscopy Unit, Humanitas Research Hospital
Rozzano, Milano, 20089, Italy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2021
First Posted
March 5, 2021
Study Start
March 1, 2021
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
September 15, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share